Hyderabad: Hyderabad-based biotechnology company GeneSys Biologics has inaugurated it’s integrated drug development facility in Genome Valley, Shameerpet.
The unit will make insulin biosimilars across the value chain from research and development to commercial manufacturing.
A biosimilar is a biologic product that is approved based on demonstrating that it is similar to a reference biologic product and has no clinical difference from the reference product.
The new facility will contribute towards the company’s global clinical programme for multiple products. It will also cater to the future commercial requirements of India and other emerging
The company which currently employs 140 people is planning to hire more people.
The four-acre facility houses a research and development centre, quality analysis and quality control labs. The unit complies to the WHO good manufacturing practices (GMP) norms.